Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jun;62(3):e23598.
doi: 10.1002/dvg.23598.

CRISPR-Cas9 delivery strategies and applications: Review and update

Ali Alizadeh Severi  1 , Bahman Akbari  1
Affiliations
Review

CRISPR-Cas9 delivery strategies and applications: Review and update

Ali Alizadeh Severi et al. Genesis. 2024 Jun.

Abstract

Nowadays, a significant part of the investigations carried out in the medical field belong to cancer treatment. Generally, conventional cancer treatments, including chemotherapy, radiotherapy, and surgery, which have been used for a long time, are not sufficient, especially in malignant cancers. Because genetic mutations cause cancers, researchers are trying to treat these diseases using genetic engineering tools. One of them is clustered regularly interspaced short palindromic repeats (CRISPR), a powerful tool in genetic engineering in the last decade. CRISPR, which forms the CRISPR-Cas structure with its endonuclease protein, Cas, is known as a part of the immune system (adaptive immunity) in bacteria and archaea. Among the types of Cas proteins, Cas9 endonuclease has been used in many scientific studies due to its high accuracy and efficiency. This review reviews the CRISPR system, focusing on the history, classification, delivery methods, applications, new generations, and challenges of CRISPR-Cas9 technology.

Keywords: CRISPR‐Cas9; HDR; NHEJ; deliver; gene editing; sgRNA.

PubMed Disclaimer

References

REFERENCES

    1. Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007). CRISPR provides acquired resistance against viruses in prokaryotes. Science, 315(5819), 1709–1712.
    1. Bolotin, A., Quinquis, B., Sorokin, A., & Ehrlich, S. D. (2005). Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin. Microbiology, 151(8), 2551–2561.
    1. Bruegmann, T., Deecke, K., & Fladung, M. (2019). Evaluating the efficiency of gRNAs in CRISPR/Cas9 mediated genome editing in poplars. International Journal of Molecular Sciences, 20(15), 3623.
    1. Burstein, D., Harrington, L. B., Strutt, S. C., Probst, A. J., Anantharaman, K., Thomas, B. C., Doudna, J. A., & Banfield, J. F. (2017). New CRISPR–Cas systems from uncultivated microbes. Nature, 542(7640), 237–241.
    1. Cevher, E., Sezer, A. D., & Çağlar, E. (2012). Gene delivery systems: Recent progress in viral and non‐viral therapy. Recent Advances in Novel Drug Carrier Systems, 31, 437–470.

Publication types

LinkOut - more resources